Faeth Therapeutics, Inc.
NASDAQ:FTHBiotechnology
Healthcare
$8.72 +5.01%
+$1.43 today
- Market cap
- $224.79M
- Beta
- -0.31
- P/E (TTM)
- -0.2
- EPS (TTM)
- -$34.65
52W Low $7.21High $37.90
Volume 0.33M
Average 0.12M
Balance Sheet
Inspect the capital base behind the business.
Assets
$22.90M
FY 2025 · Annual
-49.5% YoYLiabilities
$4.31M
FY 2025 · Annual
-38.2% YoYEquity
$18.59M
FY 2025 · Annual
-51.6% YoYBalance Sheet
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 7.16M | 17.8M | 13.01M | 9.99M | 8.67M |
| Short-term Investments | 140.46M | 89.32M | 52.75M | 31.34M | 12.52M |
| Net Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 374K | 344K | 325K | 120K | 92K |
| Total Current Assets | 148.54M | 108.59M | 67.25M | 41.93M | 21.51M |
| Property, Plant & Equipment (Net) | 4.64M | 9.72M | 7.04M | 3.38M | 1.38M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 39K | 63K | 86K | 48K | 18K |
| Total Non-current Assets | 4.68M | 9.79M | 7.12M | 3.43M | 1.4M |
| Total Assets | 153.23M | 118.38M | 74.37M | 45.36M | 22.9M |
| Account Payables | 2.46M | 4.47M | 1.69M | 244K | 689K |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 0 | 2.01M | 1.4M |
| Total Current Liabilities | 4.89M | 9.07M | 5.64M | 5.45M | 4.25M |
| Long-term Debt | 0 | 0 | 0 | 0 | 59K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 149K | 0 | 67K | 0 | 0 |
| Total Non-current Liabilities | 1.82M | 5.9M | 3.84M | 1.53M | 59K |
| Total Liabilities | 6.71M | 14.97M | 9.48M | 6.98M | 4.31M |
| Common Stock | 3K | 3K | 3K | 3K | 0 |
| Retained Earnings | (149.21M) | (197.79M) | (231.9M) | (262.05M) | (283.14M) |
| Accumulated OCI | (333K) | (1M) | (209K) | (13K) | 1K |
| Other Stockholders Equity | (0) | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 146.51M | 103.41M | 64.9M | 38.39M | 18.59M |
| Total Debt | 2.35M | 8.03M | 6.21M | 3.85M | 1.51M |
| Net Debt | (4.81M) | (9.76M) | (6.8M) | (6.15M) | (7.16M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $26.9M |
| Short-term Investments | $159.5M |
| Other Current | $2.2M |
| Total Current Assets | $188.7M |
| PP&E (Net) | $568.0K |
| Other Non-current | $80.0K |
| Total Non-current Assets | $648.0K |
| Total Assets | $189.3M |
Analysis
Selected assets total $189.3M for Latest. The largest visible component is Short-term Investments at $159.5M, about 84.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| SC 13G/A | SC 13G/A filing | Nov 13, 2026 | |
| 8-K | Current report | Nov 9, 2026 | |
| 8-K | Current report | Nov 9, 2026 | |
| 8-K | Current report | Nov 3, 2026 | |
| S-8 | S-8 filing | Nov 3, 2026 |
How much cash does FTH have?
Faeth Therapeutics, Inc. (FTH) reported $8.67M in cash and equivalents in fiscal 2025.
How much debt does FTH carry?
Faeth Therapeutics, Inc. (FTH) reported $1.51M of total debt, with net debt of -$7.16M.
Continue the stock analysis
Jump to another research area for this company.